Role of Individualized Versus Traditional Exercise in Combating Fatigue (REEN-SEP)

Role of Individualized Versus Traditional Exercise in Combating Fatigue in Fatigued Multiple Sclerosis Patients

The objective of this project will be to characterise the benefits of an exercise programme adapted to each individual's abilities compared to a traditional exercise programme with the aim of reducing perceived fatigue and improving the quality of life of Patients with multiple sclerosis.

Study Overview

Detailed Description

Chronic fatigue is a very common symptom reported (80%) by patients with multiple sclerosis (MS), regardless of the type of MS and level of disability. Despite the clinical importance of MS-related fatigue, pharmacological treatments remain quite ineffective in preventing or treating chronic fatigue.

Recently, physical activity has proven to be an effective therapy with benefits on chronic fatigue as well as on different functions (muscular, cardiorespiratory, cognitive, etc.). Nevertheless, the effects of physical exercise may vary between MS patients, as MS is a heterogeneous disease and does not affect each individual in the same way. The objective of this project will be to characterise the benefits of an exercise programme adapted to each individual's abilities compared to a traditional exercise programme with the aim of reducing perceived fatigue and improving the quality of life of Patients with multiple sclerosis.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-Étienne, France
        • CHU de Saint-Etienne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 66 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged 18 to 70 years old
  • Male or female
  • With relapsing-remitting multiple sclerosis (RRMS) as defined by McDonald's 2010 criteria.
  • Between 2 and 25 years from the onset of multiple sclerosis
  • With a high level of fatigue, corresponding to a score of Fatigue Severity Scale> 4 and Fatigue questionnaire > 38.
  • Expanded Disability Status Scale Score 5
  • Testing ≥ 4 in all leg muscles.
  • Ability to walk for 10 minutes without stopping (self-reported)
  • Affiliates or beneficiaries of a social security scheme
  • Having freely given their written consent after having been informed of the purpose, course of action and potential risks involved

Exclusion Criteria:

  • Severe cerebellar spasticity or ataxia in either leg.
  • Abnormal range of motion of the toes and/or ankle.
  • Musculoskeletal injury that interferes with pedaling.
  • High resting heart rate (>90 beats per minute).
  • Blood pressure > 144/94 mmHg.
  • Onset of a multiple sclerosis attack within 90 days prior to the study.
  • Recent adjustment of any medication or drugs that may impact on fatigue, or taking stimulants for fatigue (e.g. Modafinil).
  • Taking of neuro-active substances that may impair cortico-spinal excitability (hypnotics, antiepileptics, psychotropic drugs, muscle relaxants) throughout the study period.
  • Contraindication to the application of a magnetic field
  • History of co-morbid disease or conditions that would compromise the subject's safety during the study.
  • Participation at the same time in another medical intervention study or having participated in such a study within 30 days prior to this study.
  • Pregnant and Nursing Women
  • Women of childbearing age without effective contraception
  • Patient unable to understand the purpose and conditions of the study, incapable of giving consent
  • Patient deprived of liberty or patient under guardianship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Traditional exercise
fatigued multiple sclerosis patients with a traditional training program
Same training program for all patients in this group
Experimental: Individual exercise
tired multiple sclerosis patients with an adapted and individualized training program
Physical training program adapted and individualized according to each patient in this group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chronic fatigue score
Time Frame: Month 3
assessed using the Fatigue Severity Scale (FSS) questionnaire before and after an individualized re-training program compared to a traditional re-training program in MS patients.
Month 3

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cardiorespiratory fitness
Time Frame: Month 3
evaluated by measuring the maximum oxygen consumption (VO2max) during an incremental exercise on a cycloergometer.
Month 3
Hematological parameters
Time Frame: Month 3
red blood cell and hemoglobin levels measured by spectrophotometry.
Month 3
Inflammatory parameters
Time Frame: Month 3
c-reactive protein
Month 3
quality of sleep
Time Frame: Month 3
actigraphy measurements and sleep diary records
Month 3
cortical activation level
Time Frame: Month 3
transcranial magnetic stimulation
Month 3
cortico-spinal excitability
Time Frame: Month 3
transcranial magnetic stimulation
Month 3
neuromuscular fatigue of peripheral function
Time Frame: Month 3
electrical nerve stimulation
Month 3
Analysis overall quality of life : Fatigue questionnaire
Time Frame: Month 3
Fatigue questionnaire by Modified Fatigue Impact Scale (MFIS) results
Month 3
Analysis overall quality of life :Quality of Life
Time Frame: Month 3
Quality of Life Questionnaire by SEP-59 results
Month 3
Analysis overall quality of life :Depression
Time Frame: Month 3
Depression Questionnaire by Center for Epidemiologic Studies Depression (CES-D) results
Month 3
Analysis overall quality of life : Sleep Quality
Time Frame: Month 3
Sleep Quality Questionnaire by Pittsburgh Sleep Quality Index (PSQ-I) results
Month 3
Analysis overall quality of life : Physical Activity
Time Frame: Month 3
Physical Activity Questionnaire by Godin Leisure-Time Exercise Questionnaire (GLTEQ) results
Month 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jean Philippe CAMDESSANCHE, MD PhD, CHU Saint-Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 2, 2021

Primary Completion (Actual)

February 23, 2022

Study Completion (Actual)

June 30, 2022

Study Registration Dates

First Submitted

January 15, 2021

First Submitted That Met QC Criteria

March 10, 2021

First Posted (Actual)

March 12, 2021

Study Record Updates

Last Update Posted (Actual)

November 2, 2023

Last Update Submitted That Met QC Criteria

October 31, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Multiple Sclerosis

Clinical Trials on traditional training program

Subscribe